| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.003 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.005 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.006 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |